Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly and Co.
Looking at options history for Eli Lilly and Co LLY we detected 22 trades.
If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 59% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $181,850 and 16, calls, for a total amount of $3,057,626.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $490.0 to $830.0 for Eli Lilly and Co during the past quarter.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly and Co's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly and Co's whale trades within a strike price range from $490.0 to $830.0 in the last 30 days.
Eli Lilly and Co Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | SWEEP | NEUTRAL | 04/05/24 | $188.4 | $181.9 | $185.65 | $580.00 | $1.8M | 100 | 0 |
| LLY | CALL | SWEEP | BEARISH | 06/21/24 | $48.4 | $45.6 | $45.65 | $770.00 | $457.8K | 1.0K | 100 |
| LLY | CALL | TRADE | BEARISH | 05/17/24 | $17.35 | $16.85 | $17.04 | $830.00 | $166.9K | 778 | 403 |
| LLY | CALL | SWEEP | BULLISH | 05/17/24 | $15.1 | $13.5 | $14.37 | $830.00 | $143.5K | 778 | 101 |
| LLY | CALL | SWEEP | NEUTRAL | 09/20/24 | $60.05 | $57.35 | $58.69 | $800.00 | $64.5K | 645 | 11 |
About Eli Lilly and Co
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Having examined the options trading patterns of Eli Lilly and Co, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Where Is Eli Lilly and Co Standing Right Now?
- With a volume of 393,887, the price of LLY is down -0.55% at $763.86.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 25 days.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Eli Lilly and Co with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
